Status: current, Primitive. Date: 30-Nov 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2137201000168115 | Daratumumab (Janssen) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2137211000168117 | Daratumumab (Janssen) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daratumumab (Janssen) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daratumumab (Janssen) 100 mg/5 mL injection, 5 mL vial | Is a | True | Daratumumab (Janssen) | Inferred relationship | Some | |
| Daratumumab (Janssen) 100 mg/5 mL injection, 5 mL vial | has TP | True | Daratumumab (Janssen) | Inferred relationship | Some | |
| Daratumumab (Janssen) 100 mg/5 mL injection, 5 mL vial | has TP | True | Daratumumab (Janssen) | Inferred relationship | Some | |
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | has TP | True | Daratumumab (Janssen) | Inferred relationship | Some | |
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | has TP | True | Daratumumab (Janssen) | Inferred relationship | Some | |
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | Is a | True | Daratumumab (Janssen) | Inferred relationship | Some |
Reference Sets
FHIR